| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 37 | 2024 | 7895 | 2.580 |
Why?
|
| Meningitis, Bacterial | 3 | 2022 | 100 | 2.040 |
Why?
|
| Child Abuse | 5 | 2022 | 208 | 1.730 |
Why?
|
| Ganglioglioma | 3 | 2020 | 40 | 1.680 |
Why?
|
| Brain Neoplasms | 11 | 2023 | 4958 | 1.650 |
Why?
|
| Neuroimaging | 13 | 2023 | 401 | 1.580 |
Why?
|
| Cranial Nerves | 2 | 2024 | 28 | 1.380 |
Why?
|
| Craniocerebral Trauma | 4 | 2022 | 154 | 1.350 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 7 | 2023 | 339 | 1.350 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2018 | 909 | 1.260 |
Why?
|
| Supratentorial Neoplasms | 2 | 2020 | 77 | 1.120 |
Why?
|
| Astrocytoma | 3 | 2019 | 326 | 1.110 |
Why?
|
| Radiation Injuries | 3 | 2018 | 1471 | 0.990 |
Why?
|
| Infant | 30 | 2024 | 13999 | 0.970 |
Why?
|
| Pons | 1 | 2024 | 54 | 0.950 |
Why?
|
| Sinus Thrombosis, Intracranial | 5 | 2024 | 55 | 0.950 |
Why?
|
| Hydrocephalus | 6 | 2024 | 259 | 0.950 |
Why?
|
| Contrast Media | 7 | 2021 | 1499 | 0.910 |
Why?
|
| Ataxia | 2 | 2024 | 182 | 0.860 |
Why?
|
| Muscle Weakness | 1 | 2024 | 111 | 0.860 |
Why?
|
| Essential Tremor | 1 | 2024 | 91 | 0.850 |
Why?
|
| Gadolinium | 2 | 2021 | 169 | 0.850 |
Why?
|
| Sensitivity and Specificity | 11 | 2022 | 5162 | 0.830 |
Why?
|
| Child, Preschool | 29 | 2024 | 17061 | 0.830 |
Why?
|
| Streptococcus agalactiae | 2 | 2022 | 113 | 0.820 |
Why?
|
| Proton Therapy | 3 | 2018 | 1637 | 0.820 |
Why?
|
| Child | 43 | 2024 | 30559 | 0.780 |
Why?
|
| Brain | 12 | 2024 | 4208 | 0.760 |
Why?
|
| Encephalitis | 1 | 2022 | 153 | 0.740 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2019 | 218 | 0.700 |
Why?
|
| Ear, Inner | 1 | 2020 | 65 | 0.690 |
Why?
|
| Retrospective Studies | 34 | 2024 | 39890 | 0.660 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2022 | 7783 | 0.650 |
Why?
|
| Deep Brain Stimulation | 1 | 2024 | 403 | 0.640 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 154 | 0.630 |
Why?
|
| Skull Fractures | 1 | 2018 | 49 | 0.620 |
Why?
|
| Joint Diseases | 1 | 2018 | 71 | 0.610 |
Why?
|
| Stroke | 6 | 2023 | 1049 | 0.600 |
Why?
|
| Hemangioma, Capillary | 1 | 2017 | 26 | 0.590 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2017 | 7 | 0.590 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2017 | 24 | 0.570 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 190 | 0.560 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 100 | 0.560 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 272 | 0.550 |
Why?
|
| Diagnosis, Differential | 11 | 2022 | 4831 | 0.540 |
Why?
|
| Male | 47 | 2024 | 128315 | 0.530 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 317 | 0.530 |
Why?
|
| Female | 50 | 2024 | 148940 | 0.530 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 585 | 0.520 |
Why?
|
| Orbit | 2 | 2017 | 209 | 0.500 |
Why?
|
| Humans | 75 | 2024 | 270740 | 0.500 |
Why?
|
| Blood Volume Determination | 1 | 2014 | 9 | 0.500 |
Why?
|
| Blood Volume | 1 | 2014 | 107 | 0.470 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 342 | 0.460 |
Why?
|
| Cranial Nerve Diseases | 2 | 2012 | 77 | 0.460 |
Why?
|
| Neoplasm Grading | 2 | 2015 | 1823 | 0.440 |
Why?
|
| Adolescent | 20 | 2024 | 32767 | 0.430 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 473 | 0.430 |
Why?
|
| Mutism | 2 | 2024 | 31 | 0.430 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 106 | 0.420 |
Why?
|
| Meglumine | 3 | 2018 | 21 | 0.420 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 518 | 0.410 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 79 | 0.390 |
Why?
|
| Medulloblastoma | 3 | 2024 | 571 | 0.390 |
Why?
|
| Infant, Newborn | 8 | 2024 | 8699 | 0.390 |
Why?
|
| Teratoma | 1 | 2013 | 248 | 0.380 |
Why?
|
| Organometallic Compounds | 3 | 2018 | 209 | 0.380 |
Why?
|
| Orbital Diseases | 1 | 2012 | 123 | 0.380 |
Why?
|
| Mitochondrial Diseases | 2 | 2024 | 145 | 0.380 |
Why?
|
| Cerebellar Diseases | 2 | 2022 | 91 | 0.370 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2023 | 293 | 0.350 |
Why?
|
| Glioma | 1 | 2021 | 1978 | 0.350 |
Why?
|
| Hematoma, Subdural | 2 | 2019 | 30 | 0.310 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2008 | 9 | 0.310 |
Why?
|
| Optic Nerve Glioma | 2 | 2019 | 28 | 0.300 |
Why?
|
| Cerebellar Neoplasms | 2 | 2024 | 477 | 0.300 |
Why?
|
| Chondrocalcinosis | 1 | 2008 | 26 | 0.300 |
Why?
|
| Atlanto-Axial Joint | 1 | 2008 | 26 | 0.300 |
Why?
|
| Spinal Diseases | 2 | 2018 | 131 | 0.280 |
Why?
|
| Skull | 3 | 2022 | 251 | 0.250 |
Why?
|
| Spasms, Infantile | 2 | 2017 | 167 | 0.250 |
Why?
|
| Spinal Injuries | 2 | 2022 | 37 | 0.240 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2024 | 19 | 0.240 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 12 | 0.230 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.230 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2023 | 28 | 0.220 |
Why?
|
| Observer Variation | 2 | 2017 | 709 | 0.220 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 35 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 34 | 0.220 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 35 | 0.220 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2023 | 6 | 0.220 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2024 | 53 | 0.220 |
Why?
|
| Fever | 2 | 2024 | 521 | 0.220 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 30 | 0.210 |
Why?
|
| Optic Atrophy | 1 | 2023 | 51 | 0.210 |
Why?
|
| Facial Paralysis | 1 | 2022 | 57 | 0.210 |
Why?
|
| Cerebral Ventricles | 2 | 2023 | 106 | 0.210 |
Why?
|
| Diffuse Axonal Injury | 1 | 2022 | 10 | 0.200 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2022 | 39 | 0.200 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2022 | 8 | 0.200 |
Why?
|
| Neural Pathways | 1 | 2024 | 312 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 155 | 0.200 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 49 | 0.200 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 72 | 0.190 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2001 | 9 | 0.190 |
Why?
|
| Sphingosine | 1 | 2001 | 59 | 0.190 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 39 | 0.190 |
Why?
|
| Solvents | 1 | 2001 | 67 | 0.190 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2021 | 24 | 0.190 |
Why?
|
| Hemangioma | 1 | 2022 | 157 | 0.190 |
Why?
|
| Anemia, Sideroblastic | 1 | 2021 | 57 | 0.190 |
Why?
|
| Purpura | 1 | 2021 | 35 | 0.190 |
Why?
|
| Language Development Disorders | 1 | 2022 | 166 | 0.180 |
Why?
|
| Microcephaly | 1 | 2024 | 333 | 0.180 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2020 | 16 | 0.180 |
Why?
|
| Lysophospholipids | 1 | 2001 | 148 | 0.180 |
Why?
|
| Scalp | 1 | 2021 | 155 | 0.180 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 371 | 0.180 |
Why?
|
| Neurovascular Coupling | 1 | 2019 | 11 | 0.170 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 274 | 0.170 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 404 | 0.170 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 64 | 0.170 |
Why?
|
| Head | 2 | 2022 | 248 | 0.170 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2019 | 35 | 0.170 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2023 | 284 | 0.170 |
Why?
|
| Occipital Lobe | 1 | 2019 | 47 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2019 | 36 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 787 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 182 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 6177 | 0.160 |
Why?
|
| Iopamidol | 1 | 2018 | 9 | 0.160 |
Why?
|
| Sinusitis | 1 | 2020 | 148 | 0.160 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 339 | 0.160 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 36 | 0.160 |
Why?
|
| Gray Matter | 1 | 2018 | 60 | 0.150 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 117 | 0.150 |
Why?
|
| Gadolinium DTPA | 1 | 2018 | 173 | 0.150 |
Why?
|
| Leukocyte Count | 1 | 2019 | 735 | 0.150 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 77 | 0.150 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 159 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2021 | 412 | 0.140 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2018 | 109 | 0.140 |
Why?
|
| Nystagmus, Pathologic | 1 | 2017 | 24 | 0.140 |
Why?
|
| Myelography | 1 | 2016 | 21 | 0.140 |
Why?
|
| Craniopharyngioma | 1 | 2017 | 56 | 0.140 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 2197 | 0.140 |
Why?
|
| Glasgow Coma Scale | 1 | 2017 | 207 | 0.140 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2016 | 59 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 101 | 0.130 |
Why?
|
| Escherichia coli | 1 | 2022 | 1305 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 322 | 0.130 |
Why?
|
| White Matter | 1 | 2018 | 190 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 729 | 0.130 |
Why?
|
| Optic Nerve | 1 | 2017 | 139 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2023 | 1065 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2017 | 222 | 0.130 |
Why?
|
| Canavan Disease | 1 | 2014 | 2 | 0.120 |
Why?
|
| Goldenhar Syndrome | 1 | 2014 | 14 | 0.120 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2014 | 11 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2014 | 52 | 0.120 |
Why?
|
| Spinal Cord | 2 | 2023 | 718 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 120 | 0.120 |
Why?
|
| Neck | 1 | 2016 | 395 | 0.110 |
Why?
|
| Middle Aged | 8 | 2024 | 90352 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 316 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2015 | 313 | 0.110 |
Why?
|
| Anticoagulants | 3 | 2024 | 775 | 0.110 |
Why?
|
| Brain Concussion | 1 | 2016 | 214 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2014 | 110 | 0.110 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 1174 | 0.110 |
Why?
|
| Adult | 9 | 2023 | 82040 | 0.110 |
Why?
|
| Syndrome | 3 | 2022 | 1407 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2019 | 6224 | 0.110 |
Why?
|
| Time Factors | 2 | 2017 | 13006 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2019 | 1933 | 0.100 |
Why?
|
| World Health Organization | 1 | 2013 | 327 | 0.100 |
Why?
|
| Seizures | 3 | 2024 | 1001 | 0.100 |
Why?
|
| Spinal Cord Diseases | 1 | 2012 | 88 | 0.100 |
Why?
|
| Software | 1 | 2018 | 1355 | 0.100 |
Why?
|
| Arteriovenous Fistula | 1 | 2012 | 101 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 514 | 0.090 |
Why?
|
| Mass Screening | 1 | 2019 | 1552 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2014 | 553 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 2903 | 0.090 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 219 | 0.090 |
Why?
|
| Artifacts | 1 | 2013 | 536 | 0.090 |
Why?
|
| Incidence | 2 | 2024 | 5824 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1255 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 623 | 0.080 |
Why?
|
| Radiotherapy Dosage | 1 | 2017 | 4019 | 0.080 |
Why?
|
| Prevalence | 1 | 2017 | 3404 | 0.080 |
Why?
|
| Aged | 4 | 2024 | 73333 | 0.080 |
Why?
|
| Anisotropy | 2 | 2019 | 181 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 15218 | 0.080 |
Why?
|
| Odontoid Process | 1 | 2008 | 13 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 4960 | 0.080 |
Why?
|
| Ligaments, Articular | 1 | 2008 | 29 | 0.080 |
Why?
|
| Paresthesia | 1 | 2008 | 33 | 0.080 |
Why?
|
| Hypesthesia | 1 | 2008 | 20 | 0.080 |
Why?
|
| Cerebellum | 2 | 2022 | 470 | 0.070 |
Why?
|
| Neck Pain | 1 | 2008 | 41 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1795 | 0.070 |
Why?
|
| Spinal Fusion | 1 | 2008 | 150 | 0.070 |
Why?
|
| Chemoradiotherapy | 1 | 2015 | 2027 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 4895 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 30998 | 0.060 |
Why?
|
| Skull Neoplasms | 1 | 2005 | 68 | 0.060 |
Why?
|
| Calcinosis | 1 | 2008 | 426 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 22251 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 51 | 0.060 |
Why?
|
| Meninges | 1 | 2023 | 50 | 0.060 |
Why?
|
| Neurosurgery | 1 | 2005 | 117 | 0.060 |
Why?
|
| Risk Factors | 2 | 2024 | 17888 | 0.060 |
Why?
|
| Cerebral Aqueduct | 1 | 2023 | 10 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2023 | 39 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 69 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2024 | 188 | 0.050 |
Why?
|
| COUP Transcription Factor I | 1 | 2023 | 93 | 0.050 |
Why?
|
| Chordoma | 1 | 2005 | 170 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 98 | 0.050 |
Why?
|
| Skull Base | 1 | 2024 | 225 | 0.050 |
Why?
|
| Facial Nerve | 1 | 2022 | 58 | 0.050 |
Why?
|
| Citrulline | 1 | 2023 | 113 | 0.050 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 24 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 157 | 0.050 |
Why?
|
| Chloroform | 1 | 2001 | 6 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2017 | 13414 | 0.050 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 69 | 0.050 |
Why?
|
| Micelles | 1 | 2001 | 39 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 374 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2021 | 96 | 0.050 |
Why?
|
| Phenotype | 2 | 2024 | 6509 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 185 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 4147 | 0.050 |
Why?
|
| Time | 1 | 2021 | 183 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2001 | 143 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 265 | 0.040 |
Why?
|
| Decision Making | 1 | 2008 | 1252 | 0.040 |
Why?
|
| Arginine | 1 | 2023 | 507 | 0.040 |
Why?
|
| Emotions | 1 | 2024 | 560 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1145 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 633 | 0.040 |
Why?
|
| Research | 1 | 2022 | 427 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 9470 | 0.040 |
Why?
|
| Ethanol | 1 | 2001 | 272 | 0.040 |
Why?
|
| Pregnancy | 2 | 2024 | 8130 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 670 | 0.040 |
Why?
|
| Central Venous Pressure | 1 | 2018 | 27 | 0.040 |
Why?
|
| Echo-Planar Imaging | 1 | 2019 | 74 | 0.040 |
Why?
|
| Mutation | 3 | 2023 | 15912 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 126 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2018 | 127 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 340 | 0.040 |
Why?
|
| Temporal Lobe | 1 | 2019 | 191 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2024 | 5681 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 2353 | 0.040 |
Why?
|
| Emergencies | 1 | 2018 | 224 | 0.040 |
Why?
|
| Cytarabine | 1 | 2023 | 2014 | 0.030 |
Why?
|
| Remission Induction | 1 | 2023 | 3656 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 961 | 0.030 |
Why?
|
| Nerve Net | 1 | 2018 | 272 | 0.030 |
Why?
|
| Ear Ossicles | 1 | 2014 | 3 | 0.030 |
Why?
|
| Temporomandibular Joint | 1 | 2014 | 22 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2014 | 24 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 1297 | 0.030 |
Why?
|
| Ear Canal | 1 | 2014 | 31 | 0.030 |
Why?
|
| Prognosis | 2 | 2024 | 22505 | 0.030 |
Why?
|
| Atrophy | 1 | 2014 | 271 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2022 | 1465 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 2359 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 14617 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 606 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 3187 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 33737 | 0.020 |
Why?
|
| Foramen Magnum | 1 | 2005 | 7 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2023 | 10708 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 2005 | 125 | 0.010 |
Why?
|
| Meningioma | 1 | 2005 | 308 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2005 | 2665 | 0.010 |
Why?
|